Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA 10mg Mounjaro pen is available privately in the UK, but the price you pay depends on your provider and what that price actually covers. Since Eli Lilly raised the UK list price for higher-dose tirzepatide in September 2025, private providers have typically charged somewhere in the range of £200–£375 for a four-week pen at this dose — though headline figures often leave out consultation fees, prescription charges and delivery. Every legitimate supply route for a 10mg pen requires a valid prescription following a clinical assessment; tirzepatide is a prescription-only medicine, and no regulated pharmacy can dispense it otherwise.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The cost of a 10mg Mounjaro pen shifted noticeably after Eli Lilly revised its UK pricing from 1 September 2025. As widely reported at the time, the list price for higher-dose pens rose sharply — the 15mg pen, for instance, moved from around £122 to around £330. Private providers set their own retail prices on top of that, so if you want to understand how much 10mg Mounjaro costs across the market, the 10mg pen now typically sits in the £200–£350 band, though you'll find variation on either side.
Those are the quoted figures you'll see. Whether the number you're looking at is complete is a different question. A quick check worth doing before you commit anywhere: look up the pharmacy on the GPhC register and confirm they are authorised to dispense prescription medicines. It takes under a minute and it tells you immediately whether you're looking at a regulated UK pharmacy or not.
The Mounjaro SmPC on the electronic Medicines Compendium sets out exactly what the medicine contains, how it's stored and who it's intended for. Pricing is a commercial decision made separately; what the medicine is and what clinical standards govern its supply are not.
Not every price you see for a 10mg Mounjaro pen is an all-in figure. Some providers add a consultation fee on top, often £20–£50. Others charge separately for the prescription, the packaging, or next-day delivery. A few build aftercare support into the model; many don't.
That matters at the 10mg stage in particular. You've worked up through the earlier doses (the 5mg pen stage is typically where most people spend several months) and by 10mg you're likely asking questions: whether the dose is working, whether side effects have settled, what happens next. If the price you paid doesn't include clinical support, you're handling those questions alone.
NICE's appraisal of tirzepatide, TA1026, outlines the evidence base and the conditions under which the medicine is recommended. It's a useful read for understanding the clinical framing behind why ongoing medical review isn't optional, it's baked into how the treatment is designed to work.
At nume, we don't publish per-pen prices in this copy (current treatment pricing is shown on our treatment page) but the structure is straightforward. One price covers everything: the consultation, the prescription, the medicine itself, and free next-working-day delivery via DPD. There are no add-ons at checkout. We're also not the cheapest option on the market, and that's not an accident. The decision not to compete on price was made deliberately, because what gets cut when providers go lowest is usually the clinical infrastructure that makes treatment safe.
Every order at 10mg goes through the same process as the first: a named prescriber reviews your consultation before anything is dispensed. That review isn't automated. It takes into account where you are in treatment, how you've responded, and whether 10mg remains the right dose for you. Our clinical team handles this personally. If you have questions about your experience so far, our support team is available seven days a week.
A small saving on a 10mg pen is not the measure that protects you. The MHRA has warned publicly about counterfeit weight-loss pens sold through unregulated channels, in October 2025 a domestic manufacturing site producing fake tirzepatide pens was raided. The MHRA's Yellow Card scheme allows you to report suspect sellers if you encounter them.
The practical test is simpler than it sounds: is the pharmacy on the GPhC register, is a prescriber assessing your suitability, and is the supply chain licensed? If yes to all three, you're in the right territory. If any of those checks can't be answered clearly, the risk matters far more than the price. Our Mounjaro overview covers how to think through this properly, and if you're weighing up where to find the cheapest 10mg Mounjaro pen without compromising on safety, our FAQs answer the questions we hear most often from people at the 10mg stage. You can also find a broader breakdown of how much Mounjaro costs across all doses, or check the detail on how much the Mounjaro pen is at each stage of treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.